Date(s) - Friday, July 26, 2019
12:00 pm - 1:00 pm
Please join us for an Uber Conference with Sean Ainsworth of Immusoft. This meeting will serve as a Q&A for members, and potential members, to gather information from the CEO, ask questions about progress, and determine interest in their current funding round.
Join the Call: https://www.uberconference.com/bwaonuber
Call 716-293-7629 and use PIN 83191
Immusoft is developing a cutting edge approach to sustained delivery of protein therapeutics using a patient’s own cells. The approach is called Immune System Programming (ISP™). ISP entails collecting a type of the patient’s immune cells, called B cells. In response to immune stimulation, B cells can turn into a biofactory state known as a plasma cell. Plasma cells manufacture and secrete thousands of antibodies per second. We harness this biofactory capability of the plasma cell by programming B cells to produce a given protein therapeutics.
Once we have programmed the B cells we expand the number of them many times and differentiate them into plasma cells (or, stated simply, coax them into the biofactory state) that produce massive amounts of our therapeutic protein. Thereafter we infuse the ISP™ programmed cells back into the same patient, where they take up residence and produce therapeutic proteins for extended periods of time.
*Please include additional guest names in "comments."
Bookings are closed for this event.